TOP特許意匠商標
商標ウォッチ Twitter
公開日2025-04-02
公報種別公開国際商標公報
国際登録番号1836086
国際登録日2024-12-19
区分第5類(薬剤),第35類(広告・事務),第42類(科学・技術)
商品役務Pharmaceuticals for the treatment of immune and inflammatory disease; pharmaceutical products for immunotherapy, the treatment of inflammatory diseases, and the treatment infectious diseases.,New product commercialization services.,Drug discovery services: pharmaceutical research and development; provision of medical research and scientific research services and information in the field of pharmaceuticals, immune and inflammatory diseases, and clinical trials; medical research in the field of antibody-based therapies; medical research services in the fields of immunotherapy and inflammatory diseases.
基礎出願番号98633827
基礎出願日2024-07-04
基礎出願国US
出願人Belenos Biosciences, Inc.
OCRテキストBELENOS BIOSCIENCEBS
OCRテキスト2
OCRについて
この商標をJ-PlatPatで参照する

関連商標

Biohaven Therapeutics Ltd.
REJUTRIA
3か月前
Huang, Ke
1か月前
Aston Group Worldwide Ltd
INESSA
2か月前
ZEALAND PHARMA A/S
2か月前
GlaxoSmithKline Biologicals S.A.
RIXFLUGO
27日前
Huang, Ke
1か月前
Made By Brave Limited
ANCIENT+BRAVE
2か月前
GlaxoSmithKline Biologicals S.A.
FLUVIXGO
6日前
NUTRITIONAL WHOLESOME BLENDS PTY LTD
Blended. BYSARAH
3か月前
Beijing Compont Medical Devices Co., Ltd.
compont
1か月前
GlaxoSmithKline Biologicals S.A.
FLUVIXVY
6日前
GlaxoSmithKline Biologicals S.A.
EXFLUNA
27日前
Biohaven Therapeutics Ltd.
3か月前
Harbin Fuerjia Technology Co., Ltd.
Voolga
2か月前
Telix ARTMS Inc.
artms
6日前
MAFRA GROUP S.r.l.
MANIAC LINE
2か月前
ELEPHAS BIOSCIENCES CORPORATION
3か月前
PROVEPHARM LIFE SOLUTIONS
3か月前
Astria Therapeutics, Inc.
a
3か月前
RTI Surgical, Inc.
3か月前
CELLTRION, INC.
3か月前
Augurex Life Sciences Corp.
3か月前
Belenos Biosciences, Inc.
3か月前
Augurex Life Sciences Corp.
3か月前
Siga Technologies, Inc.
3か月前
PROVEPHARM LIFE SOLUTIONS
3か月前
Ananta Medicare Limited
3か月前
AstraZeneca AB
3か月前
Firebrick Pharma Limited
3か月前
Glaxo Group Limited
3か月前
PILLAR Performance Pty Ltd
3か月前
Nanjing Ophthalab Medical Technology Co.,Ltd.
3か月前
Liv Pur, LLC
3か月前
Giorgia Rossetto
3か月前
CGTN C.V.
3か月前
Cascade Pharmaceuticals, Inc
5か月前
続きを見る